InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,346.99
(
-0.11%
)
US TECH 100
18,488.00
(
-0.25%
)
Dow Jones
38,798.99
(
-0.22%
)
Brent Oil
79.40
(
0.00%
)
Bitcoin
69,370.94
(
0.06%
)
Post# of 252107
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Double_Bagel

Send PM Follow Ignore
Followers 14
Posts 898
Boards Moderated 0
Alias Born 03/07/2011

Double_Bagel

Re: DewDiligence post# 180874

Friday, 08/01/2014 7:15:28 PM

Friday, August 01, 2014 7:15:28 PM

Post# of 252107
It is mind boggling that HALO finished lower today than it was before the approval.

Roche's earnings call seemed to indicate that SC Herceptin was doing great with many European countries already switching over in more than 50% of the cases.

I bought more today on the drop. Seems to be de-risked more here. I am guessing that is quite unlikely that the FDA will go against a 15-1 vote.

Can't wait for the HALO earnings call. HALO went to 18 before the Adcom vote and before the Mabthera approval. Now post Hyqvia AdCom and post Mabthera launch it is trading at 9? I just don't get it.

Maybe I should just buy TWTR. It jumped what 40% because of a 1 cent beat?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up